1. Ingeniería

190 Differentiated Thyroid Cancer Patients More Than
60 Years Old Paradoxically Show an Increased Life
Expectancy
Tobias Markus Maier, Otmar Schober, Joachim Gerß, Dennis G¨orlich,
Christian Wenning, Michael Schaefers, Burkhard Riemann, and Alexis
Vrachimis
Volume 56 • Number 2 • February 2015
SNMMI NEWSLINE
9N Commentary: Quality: Commandment and Conundrum
Alexandru Bageac
196 Areas of High 18F-FDG Uptake on Preradiotherapy PET/
CT Identify Preferential Sites of Local Relapse After
Chemoradiotherapy for Non–Small Cell Lung Cancer
J´er´emie Calais, S´ebastien Thureau, Bernard Dubray,
Romain Modzelewski, Luc Thiberville, Isabelle Gardin,
and Pierre Vera
204
10N ABNM International In-Training Examination Program
J. Anthony Parker
11N In Memoriam: David L. Yuille, MD, 1942–2014
Shobha Desai
12N SNMMI Leadership Update: Clinical Trials Network:
From Clinical Trials to Practice
Virginia Pappas
13N Newsbriefs
16N From the Literature
FOCUS ON MOLECULAR IMAGING
209 Gleason Score at Diagnosis Predicts the Rate of
Detection of 18F-Choline PET/CT Performed When
Biochemical Evidence Indicates Recurrence of
Prostate Cancer: Experience with 1,000 Patients
Marino Cimitan, Laura Evangelista, Marina Hodolicˇ,
Giuliano Mariani, Tanja Baseric, Valentina Bodanza,
Giorgio Saladini, Duccio Volterrani, Anna Rita Cervino,
Michele Gregianin, Giulia Puccini, Federica Guidoccio,
Jure Fettich, and Eugenio Borsatti
216
18
222
18
165 Combined PET/MR: A Technology Becomes Mature
Hans F. Wehrl, Alexander W. Sauter, Mathew R. Divine,
and Bernd J. Pichler
INVITED PERSPECTIVES
169 Molecular Imaging of Prostate Cancer: Tapping into
the Opportunities
Wim J.G. Oyen and Igle J. De Jong
CLINICAL INVESTIGATIONS
171 Somatostatin Receptor–Targeted Radiopeptide
Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in
Progressive Meningioma: Long-Term Results of a
Phase II Clinical Trial
Nicolas Marincek, Piotr Radojewski, Rebecca A. Dumont,
Philippe Brunner, Jan M¨uller-Brand, Helmut R. Maecke,
Matthias Briel, and Martin A. Walter
177 Dose Response of Pancreatic Neuroendocrine
Tumors Treated with Peptide Receptor Radionuclide
Therapy Using 177Lu-DOTATATE
Ezgi Ilan, Mattias Sandstr¨om, Cecilia Wassberg,
Anders Sundin, Ulrike Garske–Roma´n, Barbro Eriksson,
Dan Granberg, and Mark Lubberink
183 Risk Stratification of Metastatic Neck Nodes by CT
and PET in Patients with Head and Neck Cancer
Receiving Definitive Radiotherapy
Ying-Chun Lin, Shang-Wen Chen, Te-Chun Hsieh,
Kuo-Yang Yen, Shih-Neng Yang, Yao-Ching Wang,
and Chia-Hung Kao
18
F-FDG PET/CT and Lung Cancer: Value of Fourth
and Subsequent Posttherapy Follow-up Scans for
Patient Management
Charles Marcus, Vasavi Paidpally, Alexander Antoniou,
Atif Zaheer, Richard L. Wahl, and Rathan M. Subramaniam
F-FDG or 39-Deoxy-39-18F-Fluorothymidine to
Detect Transformation of Follicular Lymphoma
Marielle J. Wondergem, Saiyada N.F. Rizvi, Yvonne Jauw,
Otto S. Hoekstra, Nikie Hoetjes, Peter M. van de Ven,
Ronald Boellaard, Martine E.D. Chamuleau, Saskia A.G.M. Cillessen,
Josien C. Regelink, Sonja Zweegman, and Jos´ee M. Zijlstra
F-Fluoride PET Used for Treatment Monitoring
of Systemic Cancer Therapy: Results from the
National Oncologic PET Registry
Bruce E. Hillner, Barry A. Siegel, Lucy Hanna, Fenghai Duan,
Bruce Quinn, and Anthony F. Shields
229 Relationship Between Alzheimer Disease–Like
Pattern of 18F-FDG and Fasting Plasma Glucose
Levels in Cognitively Normal Volunteers
Kenji Ishibashi, Airin Onishi, Yoshinori Fujiwara,
Kiichi Ishiwata, and Kenji Ishii
234 Use of 11C-PE2I PET in Differential Diagnosis of
Parkinsonian Disorders
Lieuwe Appel, My Jonasson, Torsten Danfors, Dag Nyholm,
H
akan Askmark, Mark Lubberink, and Jens S¨orensen
243 Test–Retest Reproducibility of Binding Parameters
in Humans with 11C-LY2795050, an Antagonist PET
Radiotracer for the k Opioid Receptor
Mika Naganawa, Ming-Qiang Zheng, Shannan Henry,
Nabeel Nabulsi, Shu-Fei Lin, Jim Ropchan, David Labaree,
Soheila Najafzadeh, Michael Kapinos, Johannes Tauscher,
Alexander Neumeister, Richard E. Carson, and Yiyun Huang
249 PET/CT-Derived Whole-Body and Bone Marrow
Dosimetry of 89Zr-Cetuximab
Nikolaos E. Makris, Ronald Boellaard, Arthur van Lingen,
Adriaan A. Lammertsma, Guus A.M.S. van Dongen,
Henk M. Verheul, Catharina W. Menke, and Marc C. Huisman
255 Integrated 18F-FDG PET/MR Imaging in the
Assessment of Cardiac Masses: A Pilot Study
Felix Nensa, Ercan Tezgah, Thorsten D. Poeppel,
Christoph J. Jensen, Juliane Schelhorn, Jens K¨ohler,
Philipp Heusch, Oliver Bruder, Thomas Schlosser,
and Kai Nassenstein
261 Motion Correction Strategies for Integrated
PET/MR
Sebastian F¨urst, Robert Grimm, Inki Hong,
Michael Souvatzoglou, Michael E. Casey, Markus Schwaiger,
Stephan G. Nekolla, and Sibylle I. Ziegler
BRIEF COMMUNICATIONS
270 Cortical Laminar Binding of PET Amyloid and Tau
Tracers in Alzheimer Disease
Yi Li, Wai Tsui, Henry Rusinek, Tracy Butler,
Lisa Mosconi, Elizabeth Pirraglia, David Mozley,
Shankar Vallabhajosula, Ryuichi Harada, Shozo Furumoto,
Katsutoshi Furukawa, Hiroyuki Arai, Yukitsuka Kudo,
Nobuyuki Okamura, and Mony J. de Leon
CONTINUING EDUCATION
274 Value of 18F-FDG PET and PET/CT for Evaluation
of Pediatric Malignancies
Lebriz Uslu, Jessica Donig, Michael Link, Jarrett Rosenberg,
Andrew Quon, and Heike E. Daldrup-Link
305 In Vivo PET Imaging Demonstrates Diminished
Microglial Activation After Fingolimod Treatment
in an Animal Model of Multiple Sclerosis
Laura Airas, Alex M. Dickens, Petri Elo, P¨aivi Marjam¨aki,
Jarkko Johansson, Olli Eskola, Paul A. Jones, William Trigg,
Olof Solin, Merja Haaparanta-Solin, Daniel C. Anthony,
and Juha Rinne
311 PET Imaging of Translocator Protein (18 kDa) in a
Mouse Model of Alzheimer’s Disease Using N-(2,5Dimethoxybenzyl)-2-18F-Fluoro-N-(2-Phenoxyphenyl)
Acetamide
Michelle L. James, Nadia P. Belichenko, Thuy-Vi V. Nguyen,
Lauren E. Andrews, Zhaoqing Ding, Hongguang Liu, Deepika
Bodapati, Natasha Arksey, Bin Shen, Zhen Cheng, Tony WyssCoray, Sanjiv S. Gambhir, Frank M. Longo, and Frederick T. Chin
317
123
I-Iododexetimide Preferentially Binds to the
Muscarinic Receptor Subtype M1 In Vivo
Geor Bakker, Wilhelmina A. Vingerhoets, Jan–Peter van
Wieringen, Kora de Bruin, Jos Eersels, Jan de Jong, Youssef
Chahid, Bart P. Rutten, Susan DuBois, Megan Watson, Adrian
J. Mogg, Hongling Xiao, Michael Crabtree, David A. Collier,
Christian C. Felder, Vanessa N. Barth, Lisa M. Broad,
Oswald J. Bloemen, Th´ere`se A. van Amelsvoort, and Jan Booij
323 Optoacoustic Imaging of Naphthalocyanine: Potential
for Contrast Enhancement and Therapy Monitoring
Nicolas B´ezie`re and Vasilis Ntziachristos
DEPARTMENTS
329 Book Reviews
BASIC SCIENCE INVESTIGATIONS
287
111
In-Cetuximab-F(ab9)2 SPECT and 18F-FDG PET
for Prediction and Response Monitoring of
Combined-Modality Treatment of Human Head
and Neck Carcinomas in a Mouse Model
Laura K. van Dijk, Otto C. Boerman, Gerben M. Franssen,
Johannes H.A.M. Kaanders, and Johan Bussink
329 Erratum
1A Recruitment Advertising
8A This Month in JNM
23A Information for Authors
JNM ONLINE
jnm.snmjournals.org
293 PMPA for Nephroprotection in PSMA-Targeted
Radionuclide Therapy of Prostate Cancer
Clemens Kratochwil, Frederik L. Giesel, Karin Leotta,
Matthias Eder, Torsten Hoppe-Tich, Hagop Youssoufian,
Klaus Kopka, John W. Babich, and Uwe Haberkorn
299 Can the Inflammatory Response Be Evaluated
Using 18F-FDG Within Zones of Microvascular
Obstruction After Myocardial Infarction?
Frank S. Prato, John Butler, Jane Sykes, Lynn Keenliside,
Kimberley J. Blackwood, R. Terry Thompson, James A. White,
Yoko Mikami, Jonathan D. Thiessen, and Gerald Wisenberg
Information for Authors
http://www.snmmi.org/journals/jnm_author_info
UPCOMING EDUCATION ARTICLE
Evaluation of Gynecologic Cancer with MR Imaging,
18
F-FDG PET/CT, and PET/MR Imaging
Susanna I. Lee, Onofrio A. Catalano, and Farrokh Dehdashti
For CE credit, you can access educational activities
through the SNMMI website (http://www.
snmmilearningcenter.org)